BOSENTAN ANHYDROUS
UNII XUL93R30K2

Substance Identification & Data

This profile provides standardized clinical and technical data for Bosentan Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XUL93R30K2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 147536-97-8 and the RxNorm Concept ID (RxCUI) 1468845. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XUL93R30K2

CAS Registry Number

147536-97-8

RxNorm Concept ID

1468845

Detailed Substance Profile

Preferred Name

BOSENTAN ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

XUL93R30K2

The specific atomic composition represented as a molecular structure string.

InChIKey

C27H29N5O6S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GJPICJJJRGTNOD-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81107

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

104865

Unique identification number in the NCBI database of chemical substances.

INN ID

7195

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(c(ccc1)OC)Oc2c(OCCO)nc(-c3ncccn3)nc2NS(c4ccc(C(C)(C)C)cc4)(=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bosentan Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.